Biswas, Sumi

Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies

Ko, K.-T., Lennartz, F., Mekhaiel, D., Guloglu, B., Marini, A., Deuker, D. J., Long, C. A., Jore, M. M., Miura, K., Biswas, S., et al. (2022) · Nature Communications

Malaria Research and ControlBiochemical and Structural Characterization

Cited by 32

Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies

King, L. D. W., Pulido, D., Barrett, J. R., Davies, H., Quinkert, D., Lias, A. M., Silk, S. E., Pattinson, D. J., Diouf, A., Williams, B. G., et al. (2024) · Cell Reports Medicine

Malaria Research and ControlImmunotherapy and Immune Responses

Cited by 27

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies

King, L. D. W., Pulido, D., Barrett, J. R., Davies, H., Quinkert, D., Lias, A. M., Silk, S. E., Pattinson, D. J., Diouf, A., Williams, B. G., et al. (2024) · Cell Reports Medicine

Malaria Research and ControlImmunotherapy and Immune Responses

Cited by 27

Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies

Ko, K.-T., Lennartz, F., Mekhaiel, D., Guloglu, B., Marini, A., Deuker, D. J., Long, C. A., Jore, M. M., Miura, K., Biswas, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory)

Malaria Research and ControlVector-borne infectious diseases

Cited by 4